Top

International Journal of Diabetes in Developing Countries

Published in:

01-04-2020 | Coronavirus | Letter to the Editor

Lockdown—the only solution to defeat COVID-19

Authors: Abhishek Gupta, Mahima Singla, Himanshu Bhatia, Ved Sharma

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2020

Excerpt

Sir/Ma’am, …

WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media briefing-on-covid-19---11-march-2020 (accessed on 16 March 2020).

Will warmer weather stop the spread of the coronavirus? https://www.dw.com/en/will warmer-weather-stop-the-spread-of-the-coronavirus/a-52570290

Melanie B., Anne M., Céline F., Angus C., Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th February 2020 medRxiv DOI: 2020.03.18.20036731: https://doi.org/10.1101/2020.03.18.20036731.

Alex W, Julie T, Mahen R. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020. https://doi.org/10.1016/S2666-5247(20)30003-3.

Title: Lockdown—the only solution to defeat COVID-19
Authors: Abhishek Gupta
Mahima Singla
Himanshu Bhatia
Ved Sharma
Publication date: 01-04-2020
Publisher: Springer India
Keywords: Coronavirus
COVID-19
Published in: International Journal of Diabetes in Developing Countries / Issue 2/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-020-00826-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Association of advanced glycation end products (AGEs) with endothelial dysfunction, oxidative stress in gestational diabetes mellitus (GDM)

Changes in SFRP5, WNT5A, HbA1c, BMI, PBF, and insulin resistance in men with type 2 diabetes after 12 weeks of combined exercise (HIIT and resistance)

Assessment of risk for obstructive sleep apnea by using STOP-BANG questionnaire in type 2 diabetes mellitus

The status of frailty in poor older adults with type 2 diabetes mellitus or hypertension: the case of Mexico

Phenotypic characterization of patients with type 2 diabetes mellitus

Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: a cross-sectional study from a tertiary care institute in North India

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials